A prescription neck device for migraine and cluster headache from Truvaga's maker. Real trials with mixed results, no published price, and not cleared for stress or sleep.
It's 10:40 on a Saturday. You're reading the back of a cereal box when a bright zigzag starts eating the middle of the words. You know this one. You have maybe 20 minutes before the headache lands, and your meds are at home.
If this has been happening more since your mid-40s, you're not imagining it. In a US study of more than 3,600 women with migraine, frequent headache (10 or more days a month) was about 50% more common in perimenopause than before it. That's often when people start asking about devices. Among vagus nerve devices, gammaCore is the one with the FDA paperwork.
The current model, gammaCore Emerald, recharges on a pad and comes loaded with a set number of therapy days. Prescriptions run 3, 12 or 36 months, and more days come on a refill card, also by prescription. The device lasts three years from activation. There's no app.
You find your pulse on the side of your neck, add a dab of gel, and raise the intensity until the corner of your mouth twitches slightly. Each stimulation lasts two minutes. For prevention, it's two on the same side, morning and night. For an attack, it's two at the first sign of pain, repeated if needed.
electroCore offers virtual training. I'd book it; placement takes practice.
Yes, directly. It targets the main trunk of the vagus nerve in your neck, not a small branch in the ear. In a small electroCore-funded study, researchers recorded a signal from the nerve in 11 of 12 volunteers. electroCore says the stimulation sends messages up to the brain that can block the pain signals behind an attack.
It's the reference point for the Zappers: when Truvaga cites electroCore's technology, this is the device behind it.
gammaCore's sham-controlled trials are bigger than anything else in this category has. The results are mixed, and electroCore funded or co-ran most of them.
Cluster headache. ACT1 (150 people) and ACT2 (102) both missed their main goal overall. The benefit showed up in episodic cluster headache: in ACT1, 34% responded versus 11% on sham, and in ACT2, 48% of attacks were pain-free at 15 minutes versus 6%. Chronic cluster headache did no better than sham. The FDA authorized it in 2017 on that subgroup result plus patient-preference data, and its own summary acknowledges "a degree of uncertainty." England's NICE now backs it for cluster headache.
Migraine attacks. In PRESTO (248 people), more people were pain-free at 30 and 60 minutes than with sham, but it missed its main two-hour goal (30% versus 20%).
Migraine prevention. PREMIUM (477 enrolled) didn't beat sham: about 2.3 fewer migraine days a month versus 1.8. PREMIUM II, cut short by COVID, also missed its main goal, though more people halved their migraine days (45% versus 27%). Both hinted that people with aura do better.
Outside views. An independent 2023 meta-analysis found neck stimulation raised the share of people who halved their migraine days but didn't significantly cut migraine days overall. For how to read trials like these, see the Science.
Plainly: gammaCore isn't cleared for anxiety, stress or sleep, and we found no sham-controlled trial of it for everyday anxiety or insomnia.
The closest is PTSD. In a 20-person pilot at Emory, three months of twice-daily stimulation cut PTSD symptoms 31% more than sham. The FDA gave it Breakthrough Device status for PTSD in 2022, which speeds review but isn't a clearance, and a VA trial of about 80 veterans is due to finish in 2027. The sleep evidence is thinner: a small uncontrolled migraine study and an Air Force all-nighter.
If calm and sleep are the goal, electroCore sells a version for that. Our Truvaga review covers how little it's been tested for those, too.
There isn't much to read. There's no app to rate, and the Trustpilot page has one review, from 2023: a migraine patient said it didn't help and the company wouldn't take it back. One review isn't a pattern, but it's the complaint I'd plan around.
The best real-world signal comes from clinical experts advising NICE, who estimate 25% to 50% of people with cluster headache respond. NICE says to continue only if symptoms improve within three months. The patient forums we tried wouldn't load, so we're not reporting on them.
Prices as of October 2026:
For migraine, gammaCore and Cefaly are the cleared options here. For stress, none are.
The label rules it out with an active implant such as a pacemaker, alongside another stimulator like a TENS unit, while using your phone or driving, or over broken skin or a scar.
It hasn't been tested in people with uncontrolled blood pressure or heart rate, heart disease or a recent heart attack, rhythm problems, metal near the neck, surgery that cut the vagus nerve, cancer, pregnancy, a history of brain tumor, aneurysm, bleed or head injury, or fainting or seizures. Its safety information adds narrowed neck arteries. If that's you, ask your doctor first.
Side effects were mostly brief: twitching (including a lip pull), skin irritation, face or neck pain (even toothache), headache, dizziness and tingling. Stop if you feel light-headed or have chest pain. Use it on the side of the neck, never the front.
Lie down and breathe in through your nose for four counts, out for six, for five minutes. Slow breathing is one of the simplest relaxation techniques, and US headache guidelines gave relaxation training their top evidence grade for migraine prevention back in 2000, while calling it "somewhat effective." Then start a headache diary: dates, aura, what helped. Your doctor will want it. More free options are in the Analogs.
It's FDA-cleared, not approved, which is normal for devices like this. The clearances cover headache disorders, by prescription, plus a 2020 emergency authorization for asthma symptoms in COVID-19 patients. Nothing for anxiety, stress or sleep.
For some people. It beat sham on several measures, especially in episodic cluster headache, but most of its trials missed their main goal. Give it the trial period your doctor suggests.
Usually not. UnitedHealthcare and Aetna call it unproven, and we found no Medicare coverage policy. The VA provides it.
Same company and core technology. gammaCore is a prescription device cleared for headache disorders. Truvaga is a no-prescription wellness product, cleared for nothing, with a 30-day refund for first-time buyers.
gammaCore is the most serious device in this category: real FDA clearances, real sham-controlled trials and a real prescription. It's also proof that serious doesn't mean certain. The trials are mixed, the price takes a phone call, and insurers mostly say no.
If migraine or cluster headache runs your calendar, I'd raise it with your neurologist, especially if you get aura. For coming down after a wired day, this isn't the tool. Start with the breathing. It doesn't need a prescription.
The over-the-counter sibling of a prescription headache device. Two-minute neck sessions, real engineering, thin evidence for stress and sleep, and a refund with fine print.
An ear clip with more published research than other ear devices, mostly in heart conditions. The stress and sleep numbers are thinner than the homepage suggests, and it isn't sold in the US.
Earbuds that send a gentle current into your left ear. Discreet and liked by many owners, but fiddly to set up, and its boldest sleep stats come from in-house pilots.